StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ASMB

Assembly Biosciences, Inc.

ASMB Nasdaq Pharmaceutical Preparations EDGAR ↗
$25.36
-0.70 -2.69%

Key statistics

from XBRL data in SEC filings
Market cap
$403M
Revenue (TTM)
$71.1M
Net income (TTM)
-$6.38M
EPS (TTM)
$0.08
P/E ratio
317.0
Dividend yield
Free cash flow
-$41.2M
Cash
$31.1M
Total assets
$236M
Gross margin
52-week range
$17.98 – $39.71

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Director or officer change; Shareholder vote results Jun 5, 2026 8-K Entered a material agreement; Other events May 26, 2026 8-K Regulation FD disclosure; Other events May 22, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Mar 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 19, 2026 8-K Results of operations (earnings release) Mar 19, 2026 8-K Regulation FD disclosure; Other events Dec 8, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Aug 11, 2025 8-K Regulation FD disclosure; Other events Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release); Other events Aug 6, 2025 8-K Other events Jun 25, 2025 8-K Director or officer change; Shareholder vote results Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Mar 20, 2025 8-K Results of operations (earnings release) Mar 20, 2025 8-K Other events Feb 20, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jan 3, 2025 8-K Other events Dec 26, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 19, 2024 8-K Amended charter or bylaws Dec 13, 2024 8-K Entered a material agreement Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Entered a material agreement; Unregistered sale of equity Jun 18, 2024 8-K Director or officer change; Shareholder vote results Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 28, 2024 8-K Results of operations (earnings release) Mar 28, 2024 8-K Director or officer change Mar 15, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events Feb 13, 2024